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SUMMARY
The prevalence of Neisseria meningitidis carriage is highest in teenagers and lowest in young
children. In contrast, invasive meningococcal disease is most common in young children with a
smaller secondary peak in teenagers. Data on carriage and disease were analysed to quantify the
risks of infection and disease by age and serogroup. The forces of infection for serogroups B, C,
other meningococci and Neisseria lactamica were modelled together with the risk of disease given
infection for serogroups B and C, using maximum likelihood to ﬁt the models to the available
data. The risk of meningococcal disease given infection declines steeply through childhood and
is higher for serogroup C than for serogroup B. The secondary peak in disease in teenagers
appears to be explained mostly by increased transmission although there is a suggestion that
other factors may also contribute. These analyses provide important insights and may be used
to guide further data collection and modelling studies.
INTRODUCTION
Invasive meningococcal disease is a rare consequence
of infection with Neisseria meningitidis. The incidence
of meningococcal disease is highest in young chil-
dren and declines through childhood, with a smaller
secondary peak in disease in teenagers. In contrast,
asymptomatic nasopharyngeal carriage of N. menin-
gitidis is common, with a population prevalence of
around 10% [1]. Carriage prevalence varies with
age, being highest in teenagers and lowest in young
children. Although cases of meningococcal disease
are the most important outcome in terms of public
health, they represent the tip of the iceberg in terms of
transmission, most of which occurs silently through
asymptomatic carriage. Thus, an understanding of
the transmission dynamics of the meningococcus at
a population level is crucial. N. meningitidis carriage
strains are diverse and only a subset of these (known
as hyperinvasive lineages) cause disease. Asympto-
matic infection with pathogenic and non-pathogenic
strains, including the closely related Neisseria lacta-
mica, which is carried frequently in children, may help
contribute to the development of protection against
meningococcal disease [2, 3]. However, large-scale
carriage studies are expensive and diﬃcult to conduct,
limiting the availability of these data.
Understanding the epidemiology of meningococcal
carriage and disease and the relationship between
the two is clearly important for designing eﬀective
disease control measures. Here we examine the avail-
able carriage and disease data by age and serogroup
to quantify past trends in the risk of infection, identify
the relationship between carriage and disease and
estimate the risks of infection and disease.
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METHODS
Data sources
Carriage
A large carriage survey was conducted in Stonehouse,
Gloucestershire, England following a community
outbreak of serogroup B disease in 1986 [1]. Over
5500 individuals were swabbed in this study (n=5652)
and these data, stratiﬁed by age and serogroup form
the basis of the carriage dataset for the following
analyses. Because few young children were sampled
in Stonehouse (three children <1 year old, 282
children aged 1–4 years), carriage data from<5-year-
olds from a study by Gold et al. [3], conducted in
Danbury, Connecticut in 1972 (n=3787) was used to
supplement the dataset (Table 1, Fig. 1). This is the
same data as used by Coen et al. [4] in their earlier
models of N. meningitidis, although data used here
were broadly grouped, into serogroup C, serogroup
B, other serogroups (including non-groupable strains)
and N. lactamica.
Published data from the UK Meningococcal
Carriage Study in 1999 provided information on
the number of carriers by serogroup, serotype and
serosubtype in a large sample (y14000) of 15- to
17-year-olds [5].
Disease
Laboratory reports provide the only information
on the serogroup causing meningococcal disease in
England and Wales. Isolates and clinical specimens
from cases are sent to the Meningococcal Reference
Unit (MRU) for conﬁrmation of the diagnosis and
characterization. Prior to vaccination against sero-
group C disease, most disease in the United Kingdom
was caused by serogroups B and C, while other
serogroups caused disease only occasionally.
Notable changes in the epidemiology of meningo-
coccal disease occurred during the 1990s, particularly
the increase in serogroup C disease. Two datasets
of laboratory-conﬁrmed cases were, therefore, gen-
erated. The ﬁrst was from the late 1980s/early 1990s,
which is the closest in time to the Stonehouse carriage
study as possible, and before the ‘hyperendemic’
period of serogroup C disease. Laboratory data from
1986, the year of the Stonehouse study, were not
available in the age groupings required. Analysis of
the available MRU data from 1988/1989 to 1991/1992
Table 1. Age-speciﬁc carriage prevalence for N. meningitidis (serogroups B, C and other) and N. lactamica,
using combined data from studies in Stonehouse, Gloucestershire and Danbury, Connecticut and cases of
laboratory-conﬁrmed meningococcal disease reported in England and Wales from two time periods
Age
group
(yr)
Carriage data Cases of laboratory-conﬁrmed disease
Serogroup Average 1988/89
to 1991/92 1998/1999
B (%) C (%) O (%) L (%)
Total
tested C B C B
<1 4 (0.2) 0 (0) 11 (0.6) 113 (5.7) 1970 65 243 105 332
1–4 5 (0.2) 0 (0) 15 (0.7) 317 (15.1) 2102 114 275 211 420
5–9 13 (2.7) 0 (0) 22 (4.6) 26 (5.5) 475 29 67 89 117
10–14 17 (2.8) 6 (1.0) 58 (9.7) 25 (4.2) 597 23 36 89 71
15–19 40 (6.0) 11 (1.6) 97 (14.5) 11 (1.6) 669 63 111 207 149
20–24 33 (8.4) 3 (0.8) 47 (11.9) 11 (2.8) 394 26 56 44 62
25–29 19 (4.3) 1 (0.2) 38 (8.7) 19 (4.3) 438 8 21 25 30
30–34 20 (4.8) 0 (0) 33 (7.8) 10 (2.4) 421 6 14 14 26
35–39 13 (3.6) 3 (0.8) 24 (6.6) 8 (2.2) 362 7 12 24 23
40–44 13 (3.8) 2 (0.6) 22 (6.4) 1 (0.3) 342 8 11 13 18
45–49 13 (5.2) 2 (0.8) 26 (10.5) 1 (0.4) 248 7 12 24 23
50–54 4 (1.8) 1 (0.4) 7 (3.1) 4 (1.8) 228 5 11 34 30
55–59 6 (2.3) 2 (0.8) 10 (3.9) 3 (1.2) 258 7 7 13 17
60–64 14 (5.6) 1 (0.4) 9 (3.6) 3 (1.2) 249 5 5 10 13
o65 13 (1.9) 0 (0) 19 (2.8) 5 (0.7) 686 23 19 36 51
Total 227 (2.4) 32 (0.3) 438 (4.6) 557 (5.9) 9439 395 899 938 1382
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(epidemiological years, July to June) shows that the
patterns of disease are fairly stable, so the average
incidence of disease was estimated for this period
(Table 1). The second dataset was from 1998/1999,
the time period immediately prior to the introduction
of serogroup C conjugate (MCC) vaccination in the
United Kingdom (Table 1). The diﬃculty here is that,
although the changes in disease incidence between
the early and late 1990s could clearly be observed,
we do not have information on the corresponding
changes in carriage prevalences across all ages. The
carriage rate of serogroup C meningococci in the
late 1990s as estimated in the UK teenage carriage
study was low, at 0.45% (95% CI 0.37–0.60). For
comparison, in Stonehouse, the serogroup C carrier
rate in 15- to 19-year-olds was 1.6% (95% CI
0.8–2.9), although the conﬁdence intervals around
this estimate are much wider because of the con-
siderably smaller sample size (669 individuals aged
15–19 years swabbed in Stonehouse compared to
over 14 000 aged 15–17 years in the teenage carriage
study). The overall prevalence of carriage in teenagers
for all serogroups was higher in Stonehouse (22.1%,
95% CI 19.0–25.5) [1] than reported by Maiden et al.
(16.7%, 95% CI 16.1–17.3) [5]. In eﬀect, we have
assumed that carriage prevalences remain the same
between the late 1980s and the late 1990s, even though
disease incidence increases.
Population data for England and Wales were
obtained from the Oﬃce for National Statistics
(ONS).
Data analysis
Episodes of carriage
The average number of episodes of carriage (by sero-
group) an individual is likely to experience in a life-
time (assumed to be 75 years) was estimated from
the carriage prevalence data. In this analysis, the
incidence of carriage at each year of age (Ii) was
estimated from the relationship,
Ii=
Pi
d
, (1)
where Pi is the prevalence of carriage at age i and d
is the average duration of carriage. The cumulative
incidence of carriage by age and serogroup were
then estimated. We assumed there was no immunity
to carriage and that individuals carried only one
strain at a time. The duration of carriage was assumed
to be 9 months [6] for meningococcal carriage and
4 months [3] for N. lactamica carriage, according to
the published literature. The sensitivity of the results
to changes in the duration of carriage was tested,
including a shorter duration of carriage with sero-
group C than other meningococcal serogroups.
Risk of disease given infection
Age eﬀects. To explore the eﬀect of age further
we examined the ratio of disease incidence to
carriage incidence by age group using the Stonehouse/
Danbury carriage data and the disease dataset from
the late 1980s/early 1990s, as described above. The
yearly incidence of carriage by age and serogroup was
estimated from the prevalence data using equation
(1), assuming carriage duration of 9 months. The
average annual age-speciﬁc incidence of laboratory-
conﬁrmed disease between 1988/1989 and 1991/1992
was then divided by the age-speciﬁc incidence of
carriage to generate a case:carrier ratio, which is
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Fig. 1. Comparison of age-speciﬁc prevalence of (a) N. me-
ningitidis and (b) N. lactamica carriage in Stonehouse (&)
and Danbury (m). The upper and lower 95% conﬁdence
intervals are shown.
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eﬀectively the risk of disease given infection. The
95% conﬁdence intervals for the proportion of
individuals acquiring carriage in one year were
estimated and used as the basis for calculating the
95% conﬁdence intervals for the risk of disease given
infection. This approach assumes that the case data
are complete and not based upon a population
sample.
Serogroup eﬀects. The ability of meningococcal
strains to cause invasive disease and their subsequent
virulence are variable. In recent years serogroup C
strains (of the sequence type 11 clonal complex) have
demonstrated ‘hypervirulence’, associated with a
higher risk of death [7]. Whether these serogroup C
strains are also ‘hyperinvasive’ can be investigated
by comparing the risk of disease given infection for
diﬀerent serogroups. Recent carriage data is only
available for teenagers [5] so the serogroup-speciﬁc
risks of disease given infection were estimated for this
age group (15–19 years) over two time periods (late
1980s/early 1990s and late 1990s).
Age at ﬁrst infection
The proportion of infections occurring in individuals
who had not been previously infected (i.e. ﬁrst infec-
tions) was calculated by year of age by taking the
negative exponential of the cumulative incidence of
carriage as estimated above, i.e.
e
x
R a
0
l(a)da
, (2)
Estimating the forces of infection and risk of disease
given infection
Models were created to formally describe the risks
of infection and disease. The force of infection is
deﬁned as the per capita rate at which susceptibles
acquire infection [8], where, in this case, infection
may result in carriage or disease. A SIS (susceptible–
infected– susceptible) model was constructed to
estimate the forces of infection for meningococcal
serogroups (C, B and other) and N. lactamica and the
risk of disease given infection with serogroups B
and C. It was assumed that simultaneous carriage of
more than one serogroup did not occur. Individuals
were assumed to be at risk of meningococcal disease
at the point of infection and not throughout the
entire episode of carriage. This is consistent with
observations that most cases occur within a few days
of meningococcal acquisition [9, 10], although there
are documented exceptions to this [11].
A suitable function was derived to describe the
age- and serogroup-speciﬁc forces of infection
(Appendix 1). Each ‘ infection’ (C, B, O meningococci
and N. lactamica) was described using ﬁve parameters
(20 in total). The recovery rate was ﬁxed to minimize
the number of parameters to be estimated and was
assumed to be the inverse of the average duration
of carriage (9 months for meningococci [6], 4 months
for N. lactamica [3]). A function was also derived to
describe the risk of disease given infection by age
for serogroups B and C (Appendix 1), resulting in
six further parameters to estimate. Because disease
caused by serogroups other than B and C is rare,
for simplicity only serogroups B and C disease were
modelled here. The model parameters were ﬁtted to
the Stonehouse and Danbury carriage data simul-
taneously using maximum-likelihood techniques [12]
(Appendix 2).
Models were created for two time points. The ﬁrst
was ﬁtted to disease data from the late 1980s/early
1990s (the average number of cases between 1988/
1989 and 1991/1992) and the Stonehouse/Danbury
carriage dataset described above, the second was
ﬁtted to the same carriage dataset and disease inci-
dence data from the late 1990s. The force of infection
was allowed to vary in the two models, but since
the models were ﬁtted to the same data on carriage
prevalence (because of a lack of modern carriage
data), the increase in disease incidence from the
early to late 1990s will be mostly explained by an
increased risk of disease given infection. Although
not ideal, this is at least consistent with the evidence
that serogroup C strains in the 1990s were hyper-
invasive.
RESULTS
Episodes of carriage
A typical individual might expect to experience
around four episodes of serogroup B meningococcal
carriage, seven episodes of other meningococci, six
episodes of N. lactamica carriage and 0.5 episodes
of serogroup C carriage over their lifetime (Fig. 2).
Given that, on average, an individual will experience
10 carriage episodes in the ﬁrst 30 years of life, if
there is any immunity against carriage it is likely to
be short lived. These results are sensitive to changes
in the duration of carriage. For example, if the
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duration of meningococcal carriage is doubled (to 18
months) then the average number of meningococcal
infections in a lifetime will halve to around ﬁve.
Similarly, if the duration of carriage is halved to
4.5 months, then the average number of carriage
episodes will double. If the duration of serogroup C
carriage is assumed to be 3 months, then the average
number of episodes experienced per lifetime is 1.5.
Risk of disease given infection
Figure 3 shows the age-speciﬁc risk of disease given
infection, using the Stonehouse/Danbury carriage
data and disease data from both the late 1980s/early
1990s (Fig. 3a) and the later 1990s (Fig. 3b). The ratio
of cases:carriers is highest in infants and declines
throughout childhood and it appears that individuals
become less susceptible to disease as they grow older.
There is no major change in the risk of disease given
infection for 15- to 19-year-olds implying that the
increase in disease incidence in this age group can
be reasonably explained by increased exposure due
to higher rates of carriage. In older adults the ratio
appears to be fairly stable except for a slight increase
in other serogroups. The risk of disease for all
serogroups is higher in the late 1990s compared to
the late 1980s/early 1990s (Fig. 3) but this analysis
does not allow for possible changes in carriage. For
younger adults (aged 15–19 years) it is possible to
compare the risk of disease given infection in the
late 1980s/early 1990s with the late 1990s using two
sources of carriage data appropriate to the time
period of disease (Table 2). The risk of disease
given infection is higher for serogroup C than for
serogroup B at both time points although the diﬀer-
ence is more marked when modern data are used.
Other serogroups rarely cause disease and are carried
frequently, so the risk of disease given infection is
much lower than serogroups B or C. There is no
information on how the duration of carriage might
vary between diﬀerent strains and between the diﬀer-
ent time points.
First infections
One reason for the apparent decline in the risk of
disease by age could be a higher risk of disease on
ﬁrst exposure to a meningococcus. Individuals who
have never been a carrier (naive individuals) will not
have the beneﬁt of immunity (to disease) acquired
through previous episodes of carriage [13]. Con-
versely, individuals who have previously been a
carrier, while still susceptible to carriage may
have developed some protection against disease. In
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1990s (Table 1) and the Stonehouse/Danbury carriage
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(Table 1) and the Stonehouse/Danbury carriage dataset.
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children, N. lactamica infection is most common and
90% of individuals have been infected by age 6 years.
By age 18 years, we estimate that 90% of individuals
have also been infected with non-C meningococci,
although fewer than 50% of people will ever be
infected with serogroup C meningococci in their life-
time. Using serogroup B as an example (Fig. 4), we
can see that the ratio of cases to carriers appears
to decline more quickly than the proportion of
individuals who have not previously experienced an
episode of serogroup B carriage. If we assume that
immunity generated through previous episodes of
carriage is the main factor in reducing the risk of
disease given infection then episodes of carriage
of other meningococcal serogroups and N. lactamica
must be important, i.e. there must be some cross-
protection against disease.
Forces of infection and risk of disease given infection
The best-ﬁtting force-of-infection parameters for
the SIS model structure were estimated and the
resulting carriage prevalence curves are compared to
the observed data in Figure 5. The model appears
to ﬁt well, although the prevalence of carriage for
serogroup B and other serogroups (O) may be
underestimated in older teenagers. Signiﬁcant varia-
bility, not explained by the model, remains. A more
complex function may require even more parameters,
which may oﬀset any future gains from obtaining
a ‘better ﬁt ’, especially when the variability in the
data may be due to small numbers of observations
in each data point.
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Table 2. Risk of disease given infection, by meningococcal serogroup in 15- to 19-year-olds in two time periods
Serogroup No. carriers
Carriage
incidence
(/100 000
per year)* Cases
Disease
incidence
(/100 000)
Risk of disease
given infection
r104 (95% CI)
(a) Late 1980s/early 1990s : disease data from 1988/99 to 1991/1992 (Table 1), carriage data from
the Stonehouse carriage study [1]
B 40 7972 111 3.22 4.04 (3.14–5.37)
C 11 2192 63 1.82 8.30 (4.96–14.44)
Not groupable/other 97 19 332 4 0.12 0.06 (0.05–0.07)
Denominator 669
(individuals
swabbed in
carriage study)
3 434 500
(population aged
15–19 years in
1990, ONS)
(b) Late 1990s : disease data from 1998/1999 (Table 1), carriage data from Maiden et al. [5]
B 578 5480 149 4.77 8.70 (8.12–9.33)
C 63 597 207 6.63 110.9 (89.7–139.0)
Not groupable/other 1708 16 193 37 1.18 0.73 (0.70 tox0.76)
Denominator 14 064
(individuals
swabbed in
carriage study)
3 124 000
(population aged
15–19 years in
1998, ONS)
* Carriage incidence per year estimated from reported carriage prevalence and an average duration of carriage (9 months).
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The age-speciﬁc risk of disease given infection
was estimated using the disease data from the early
1990s and 1998/1999 using the function described
in Appendix 1. The resulting deviance for the early
1990s model was 290, on 178 D.F. In comparison, the
late 1990s disease incidence model had a deviance
of 323 on 178 D.F. For both time points, the risk of
disease given infection was higher for serogroup C
than serogroup B and, as shown earlier in Table 2,
serogroup C strains were more invasive in the late
1990s compared to the early 1990s. The parameter
estimates for the late 1990s model are reported in
Appendix 1.
The incidence of meningococcal disease in the ﬁrst
3 months of life is much lower than the incidence
of disease in those aged 3–11 months (7.3/100 000
compared to 20.6/100 000), probably because of
maternal immunity [14]. This distinction may be
important when estimating the impact of routine
vaccination schedules, which currently start at 2
months of age. The risk of disease given infection
was re-estimated for <1-year-olds (assuming the
force of infection is similar throughout the ﬁrst
year), stratifying by those agedf3 months and 3–11
months.
The risk of disease given infection in children
aged f3 months was approximately one third of
that in infants aged 3–11 months (0.036 vs. 0.11).
DISCUSSION
Individuals are likely to experience many episodes
of carriage with N. meningitidis and N. lactamica
through their lifetimes, which is probably important
in developing and maintaining immunity to meningo-
coccal disease [2, 15]. The force of infection is clearly
variable by age and serogroup, with meningococcal
carriage being most common in teenagers and
carriage of N. lactamica most common in young
children. The risk of meningococcal disease given
infection declines steeply through childhood, as both
innate and speciﬁc immunity against N. meningitidis
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develops [15]. The risk of disease given infection is
higher for serogroup C than for serogroup B. This
diﬀerence was particularly marked in the late 1990s,
with serogroup C estimated to be over 12 times more
invasive than serogroup B, at least in teenagers. The
risk of disease given infection in the late 1990s
was higher for all serogroups, due to both a higher
incidence of disease and a lower prevalence of
carriage compared to the late 1980s/early 1990s. The
higher incidence of disease in the late 1990s may be
in part due to improved surveillance [16], but for
serogroup C disease the increase was accompanied
by a shift in the age distribution and a change in the
most prevalent serotype (2a), indicating a real change
in the epidemiology [16]. The lower overall carriage
prevalence observed in teenagers in 1999 compared
to 1986 may be because the Stonehouse study was
conducted in a single community experiencing an
outbreak of disease, whereas the later carriage study
took samples from many sites around the country.
The detection of carriage also varies according to
the skill of the swabber and the microbiological
techniques used, therefore, we cannot be certain that
there was a true decline in carriage over the decade.
Although the risk of disease given infection gener-
ally declines with age (Fig. 3), there appears to be
a slight increase in risk for teenagers. This implies
that while most of the secondary peak in disease in
young adults can be accounted for by increased
transmission, there may also be other factors, inde-
pendent of transmission, which increase susceptibility
to disease in this age group. These may include
passive smoking, to which exposure seems likely to
increase during teenage and is associated with an
increased risk of meningococcal disease [17]. It would
be helpful to identify these secondary factors, but it
may also be desirable to investigate the potential
for control measures aimed at reducing transmission
and exposure to meningococci in teenagers (although
an improved understanding of the way episodes of
carriage contribute to protection from disease would
be important).
Two major problems with the carriage dataset used
in this work are that two diﬀerent datasets were
amalgamated and that the carriage studies are not
recent. As previously discussed [4], the amalgamation
of two studies conducted in diﬀerent countries in
diﬀerent decades is far from ideal, but it was essential
to increase the number of young children in the
dataset. Both studies used similar microbiological
techniques, and were conducted in countries that
have similar meningococcal disease epidemiology.
Although carriage of N. lactamica is similar in the
two datasets, there are diﬀerences in the prevalence of
meningococcal carriage, which appears to be higher
in the Stonehouse dataset. However, for these
preliminary investigations we felt it would be more
misleading to ignore carriage in young children (in
particular carriage of N. lactamica which is common
in this age group), in whom the burden of meningo-
coccal disease is high. We cannot be sure that there
have not been major changes in the populations
of circulating meningococci since the time of the
carriage studies, or indeed that they were representa-
tive of the UK population at that time. There are,
however, no suitable modern data across all ages
available for analysis and we rely heavily on the
assumption that the age-speciﬁc patterns of carriage
remain similar; thus, the circulating strains were
more invasive and not more transmissible than in
the late 1980s. The low prevalence of serogroup C
carriage in teenagers in the 1999 study [5] suggests
that this may not be an unreasonable assumption.
Recent cross-sectional carriage prevalence data would
be very valuable, but unfortunately the carriage
study that was conducted in 1999 [5] focused on a
narrow age range (15- to 17-year-olds only), rather
than across the population to facilitate the collection
of the largest possible number of strains. Large-scale
carriage studies are expensive and logistically diﬃ-
cult, so it is unlikely that another cross-sectional
carriage study across all ages will be conducted in
the near future in the United Kingdom. Alternative
approaches to estimating the incidence of carriage
could be considered. For example, Auranen estimated
the incidence of subclinical Haemophilus inﬂuenzae
type b (Hib) infection using back-calculation tech-
niques applied to serological data [18].
Coen et al. [4] suggested that a model in which
carriage of N. lactamica conferred temporary im-
munity against carriage with N. meningitidis was
more appropriate than a simple SIS model of car-
riage. We favoured the SIS approach here for several
reasons. First, if there is immunity against carriage
then given the large number of carriage episodes
experienced (an average of 10 carriage episodes by
age 30), immunity is likely to be short lived. Second,
protection within and between meningococcal sero-
groups is likely to be important as well as cross-
protection from N. lactamica. Information on the
degree of cross-protection is scarce and model struc-
tures accounting for cross-protection quickly become
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very complex. The SIS model is a much simpler
starting point from which these relationships can be
investigated further. Third, there is clear evidence
from immunological studies that carriage episodes
are important in generating immunity against disease
[2] but not necessarily against infection resulting
in carriage. This immunity can be accounted for
implicitly in the risk of disease given infection in the
current model structures.
This work provides the basis for further studies
and highlights areas worthy of further investigation.
A major area of work is to develop, parameterize
and apply mathematical models of meningococcal
carriage and disease. In 1999, the United Kingdom
introduced meningococcal serogroup C conjugate
(MCC) vaccine into the infant immunization schedule
and targeted all children aged<18 years in a catch-up
campaign [19]. The vaccine campaign reduced the
prevalence of serogroup C carriage [5], leading to
large herd immunity eﬀects [20]. To model the
impact of vaccination, transmission dynamic models,
which are able to capture the indirect eﬀects of
vaccination, should be used (static models of MCC
vaccination such as developed by Tuckwell et al. [21]
are not able to capture herd immunity). This work
provides the foundations for structuring and par-
ameterizing such transmission dynamic models,
which may be useful, for example, to predict the
duration of herd immunity or the eﬀects of future
changes to the MCC vaccination schedule. Although
the same caveats regarding the carriage data apply
to the force-of-infection estimates, it should be noted
that these models were ﬁtted to, and are consistent
with, disease data in addition to the amalgamated
carriage dataset. We assumed that the duration of
meningococcal carriage was 9 months on average,
but it has been postulated that the C2a strains that
were prevalent in the late 1990s are more trans-
missible, but also have a shorter duration of carriage
to maintain their low prevalence. These assumptions
could be tested in a transmission dynamic model by
comparing model predictions to observed data of
disease incidence.
The potential for additional data collection and
modelling studies to look at the age-speciﬁc risk of
disease and the role of carriage in the development
of immunity against disease is also highlighted. The
decline in the risk of disease given infection appears
similar to that of the depletion of naive individuals
who have not been previously exposed to meningo-
cocci and N. lactamica, at least in children (Fig. 4).
Of course this relationship may just be an artefact of
age, but since carriage has been shown experimentally
to be an immunizing event [2, 3] it may be due to
immunity built up from exposure to carriage, in
which case, cross-protection from N. lactamica and
other serogroups is likely to be important. An under-
standing of these mechanisms may be essential when
considering vaccines against strains more commonly
carried than serogroup C or vaccines based on N.
lactamica outer membrane vesicles that are currently
being developed [22]. In these cases, vaccination may
disrupt the generation of natural immunity and
boosting, with potentially deleterious eﬀects. If the
degree of cross-protection between meningococcal
serogroups and between N. meningitidis and N. lac-
tamica can be quantiﬁed, mathematical models could
be developed to explore the possible consequences
of such a vaccine strategy.
APPENDIX 1
A function to model the force of infection
The prevalence of carriage by serogroup and age
group are shown in Table 1. Since the duration of
carriage is assumed to be constant this approximates
the shape of the curves for the forces of infection,
therefore, a function of an appropriate shape to
model these curves is needed. Coen et al. [4] used a
variation of the functional form suggested by
Farrington [23]. We preferred to use a smoother
function, and derived the following function, which is
a combination of two curves.
l(a)= b+
(cxb)
1+ex(axT)=w
 
1+
(dx1)
1+ex(axT)=w
 
,
where a=age, T=age at peak of carriage, w=width
of carriage peak and b, c and d are constants. If a
is small (young age) then the force of infection tends
towards the value of b, if a is large (old age) then the
force of infection tends towards cd.
A function to model the risk of disease given infection
The preliminary analysis suggested that a suitable
function for describing the risk of disease given
infection (denoted here as hi, where i=age) would be
one that declined steeply in younger ages, plateauing
at older ages (Fig. 5). The following functional form
was used:
log10 hi=a  exbi+c:
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The best-ﬁtting model parameters are shown in
Table 3.
APPENDIX 2
Maximum-likelihood techniques [12, 24] were used to
simultaneously ﬁt the force-of-infection parameters
and the risk of disease given infection parameters to
the carriage and disease data.
A multinomial model was used to ﬁt the parameters
to the carriage dataset. The log likelihood (log L)
of this model is :
logL=
Xn
i=1
Ci log ci+Bi log bi+Oi log oi+Li log li
+Si log si+constant,
where i=age group, C=observed number of C
carriers, c=predicted prevalence of C carriers, B=
observed number of B carriers, b=predicted preva-
lence of B carriers, L=observed number of L carriers,
l=predicted prevalence of L carriers, S=observed
prevalence of susceptibles, s=predicted prevalence
of susceptibles.
A Poisson model was used to ﬁt the parameters
to the disease data. The log likelihood of the model
was calculated as follows:
logL (disease)=
X
i
niB logmiBxmiB
+
X
i
niC logmiCxmiC,
where niB=the number of observed serogroup B
cases and miB=the number of serogroup B cases
predicted by the model, niC=the number of
observed serogroup C cases and miC=the number
of serogroup C cases predicted by the model and
i=age.
The saturated log likelihood (i.e. the log likelihood
that would be expected if the model predicted the
observed data perfectly) was derived and the deviance
was calculated as twice the diﬀerence between the
model log likelihood (log L) and the saturated
log likelihood (log L^) : deviance=2(log L^ – log L).
The deviance of the model was minimized by simul-
taneously altering the force-of-infection and risk
of disease given infection parameters using the
Solver tool within Microsoft Excel (which utilizes
the downhill simplex method). There were 209 D.F.
for the carriage and disease model, comprising
34r4–20=116 for carriage and 34r3–9=93 for
disease.
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Table 3. Force of infection (li) parameters for C, B, O and L, and parameters for the risk of disease given
infection (hi) for serogroups C and B. Estimated using disease incidence data from 1998 to 1999, assuming
a duration of carriage of 9 months for N. meningitidis and 4 months for N. lactamica
Parameter C B O L
Force of infection, li
b 1.69r10x4 8.15r10x4 4.16r10x4 1.00r10x6
c 1.22r10x2 6.23r10x2 8.08r10x2 0.214
d 2.69r10x2 6.76r10x2 7.85r10x2 2.92r10x2
T 207 224 215 29
w 17 20 45 13
Risk of disease given
infection, hi
a 1.88 2.71
b 0.11 0.10
c x2.83 x3.89
Total model deviance=367.
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